|
|
|
Insider
Information: |
Barer Sol J |
Relationship: |
Director |
City: |
Warren |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
10 |
|
Direct
Shares |
5,895,217 |
|
Indirect Shares
|
2,793,946 |
|
|
Direct
Value |
$81,903,331 |
|
|
Indirect Value
|
$6,974,534 |
|
|
Total
Shares |
8,689,163 |
|
|
Total
Value |
$88,877,865 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Celgene Corp |
CELG |
Director |
2011-01-13 |
692,192 |
2011-01-13 |
61,281 |
Premium* |
|
Amicus Therapeutics Inc |
FOLD |
Director |
2013-03-15 |
45,000 |
2009-11-04 |
0 |
Premium* |
|
Aegerion Pharmaceuticals, Inc. |
AEGR |
Director |
2016-11-29 |
0 |
2011-05-05 |
0 |
Premium* |
|
Inspiremd, Inc |
NSPR |
Director |
2016-03-21 |
1,141,690 |
2016-03-21 |
170,000 |
Premium* |
|
Aevi Genomic Medicine Inc |
GNMX |
Director |
2019-12-05 |
0 |
2019-12-05 |
0 |
Premium* |
|
Cervomed Ord Shs |
CRVO |
Chairman of the Board,... |
2014-06-06 |
1,011,072 |
|
0 |
Premium* |
|
Contrafect Corp |
CFRX |
Director |
2017-07-25 |
815,933 |
|
0 |
Premium* |
|
PDS Biotechnology Corp |
PDSB |
Director |
2015-10-06 |
0 |
2019-03-15 |
678,075 |
Premium* |
|
Teva Pharmaceutical Industries L... |
TEVA |
Director |
2023-08-04 |
371,516 |
2018-09-03 |
0 |
Premium* |
|
Neximmune, Inc. |
NEXI |
Director |
2022-11-17 |
1,817,814 |
2022-11-17 |
1,884,590 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
122 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CELG |
Celgene Corp |
Chief Operating Officer |
|
2005-09-07 |
4 |
D |
$52.70 |
$9,078,576 |
D/D |
(172,269) |
401,543 |
|
- |
|
GNMX |
Aevi Genomic Medicine Inc |
Director |
|
2015-03-20 |
4 |
B |
$8.45 |
$422,500 |
D/D |
50,000 |
407,000 |
2.39 |
- |
|
CELG |
Celgene Corp |
Chief Operating Officer |
|
2005-09-07 |
4 |
OE |
$8.83 |
$3,650,424 |
D/D |
291,500 |
421,788 |
|
- |
|
GNMX |
Aevi Genomic Medicine Inc |
Director |
|
2017-04-26 |
4 |
B |
$1.54 |
$154,340 |
D/D |
100,000 |
507,000 |
2.39 |
- |
|
CELG |
Celgene Corp |
Chief Executive Officer |
|
2008-10-30 |
4 |
S |
$63.38 |
$15,869,191 |
D/D |
(250,388) |
543,884 |
0 |
- |
|
CELG |
Celgene Corp |
Chief Executive Officer |
|
2009-09-14 |
4 |
S |
$52.12 |
$31,274,460 |
D/D |
(600,000) |
543,884 |
0 |
- |
|
NEXI |
Neximmune, Inc. |
Director |
|
2021-02-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
567,632 |
|
- |
|
PDSB |
PDS Biotechnology Corp |
Director |
|
2015-10-06 |
4 |
A |
$0.00 |
$0 |
I/I |
587,810 |
587,810 |
0 |
- |
|
CELG |
Celgene Corp |
Executive Chairman |
|
2010-09-08 |
4 |
D |
$53.98 |
$8,072,493 |
D/D |
(149,546) |
599,714 |
0 |
- |
|
GNMX |
Aevi Genomic Medicine Inc |
Director |
|
2017-04-28 |
4 |
B |
$1.57 |
$156,670 |
D/D |
100,000 |
607,000 |
2.39 |
- |
|
CELG |
Celgene Corp |
officerTitle |
|
2005-12-28 |
4 |
OE |
$2.79 |
$746,891 |
D/D |
267,540 |
613,673 |
|
- |
|
PDSB |
PDS Biotechnology Corp |
Director |
|
2015-10-06 |
4 |
B |
$11.00 |
$495,000 |
I/I |
45,000 |
632,810 |
2.1 |
- |
|
PDSB |
PDS Biotechnology Corp |
Director |
|
2015-10-06 |
4 |
A |
$6.17 |
$78,575 |
I/I |
12,735 |
645,545 |
0 |
- |
|
PDSB |
PDS Biotechnology Corp |
Director |
|
2017-07-07 |
4 |
OE |
$2.39 |
$29,947 |
I/I |
12,530 |
658,075 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2010-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
59,144 |
658,858 |
0 |
- |
|
PDSB |
PDS Biotechnology Corp |
Director |
|
2019-03-15 |
4 |
OE |
$0.00 |
$0 |
I/I |
20,000 |
678,075 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2011-01-13 |
4 |
AS |
$57.38 |
$4,315,134 |
D/D |
(75,200) |
692,192 |
0 |
- |
|
CELG |
Celgene Corp |
Chief Operating Officer |
|
2006-04-07 |
4 |
OE |
$8.41 |
$199,977 |
D/D |
20,884 |
713,150 |
|
- |
|
CELG |
Celgene Corp |
Chief Executive Officer |
|
2007-06-08 |
4 |
AS |
$58.00 |
$580,000 |
D/D |
(10,000) |
730,868 |
0 |
- |
|
CELG |
Celgene Corp |
Chief Executive Officer |
|
2007-12-10 |
4 |
OE |
$12.59 |
$99,974 |
D/D |
7,892 |
738,760 |
0 |
- |
|
CELG |
Celgene Corp |
Chief Executive Officer |
|
2007-06-07 |
4 |
AS |
$59.14 |
$26,836,956 |
D/D |
(453,770) |
740,868 |
0 |
- |
|
CELG |
Celgene Corp |
Executive Chairman |
|
2010-09-08 |
4 |
OE |
$42.39 |
$7,164,588 |
D/D |
169,016 |
749,260 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2011-01-13 |
4 |
OE |
$26.35 |
$2,859,871 |
D/D |
108,534 |
767,392 |
0 |
- |
|
CFRX |
Contrafect Corp |
Director |
|
2014-07-28 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
775,933 |
|
- |
|
CELG |
Celgene Corp |
Chief Executive Officer |
|
2008-07-30 |
4 |
AS |
$73.73 |
$5,898,128 |
D/D |
(80,000) |
778,448 |
0 |
- |
|
122 Records found
|
|
Page 3 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|